Zetia and Cancer

Links shared publicly online about this topic

Follow-Up to the August 2008 Early Communication About an Ongoing Safety Review of Ezetimibe/Simvastatin (marketed as Vytorin), Simvastatin (marketed as Zocor) and Ezetimibe (marketed as Zetia) - FDA Investigates a Report from the SEAS Trial

fda.gov — “In august 2008, the u.s. food and drug administration (fda) issued an early communication describing a possible association between the use of vytorin – a combination of simvastatin (zocor) and ezetimibe (zetia) – and an increased risk of cancer and cancer-related death compared to placebo.View full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on December 22, 2009 at 4:31 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

RT @FDA_Drug_Info: Follow-Up to the Aug. 2008 Early Communication on Vytorin, Zetia, Zocor and the SEAS Trial. http://bit.ly/FU_SEAS

2 years ago...

Ezetimibe and cancer

theheart.org — “Over a four-year period, the rates of cancer-associated adverse events and the proportion of all reported adverse events related to cancer were less than event rates observed with other potent cholesterol-lowering medications.View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on March 25, 2009 at 10:01 pm By:

theheartorg Shelley Wood Cardiology

FDA postmarketing surveillance data show no cancer risk with ezetimibe http://tinyurl.com/cazb7s

3 years ago...

Ezetimibe and cancer risk

theheart.org — “Based on current information, the agency said an association between ezetimibe and cancer risk or cancer-related mortality is not likely, although this association can't be definitively ruled out yet.View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on December 22, 2009 at 9:39 pm By:

Is Vytorin Cancer Risk Real?

webmd.com — “Is there really a link between the cholesterol-lowering drug Vytorin and cancer? This WebMD FAQ tells you what is and isn't known.View full resource at webmd.com

  • View Related
  • Share

Most Recently Shared on August 23, 2008 at 12:22 am By:

WebMD_News WebMD_News Health News

WebMD Health News Is Vytorin Cancer Risk Real?: Is there really a link between the ch.. http://tinyurl.com/6efkqt

4 years ago...

FDA to Explore Possible Vytorin-Cancer Link

webmd.com — “The FDA is investigating a report from the SEAS trial of a possible association between use of the drug Vytorin and increased cancer risk.View full resource at webmd.com

  • View Related
  • Share

Most Recently Shared on August 22, 2008 at 2:22 am By:

WebMD_News WebMD_News Health News

WebMD Health News FDA to Explore Possible Vytorin-Cancer Link: The FDA is investigati.. http://tinyurl.com/6nqy3r

4 years ago...

FDA: Vytorin Unlikely to Up Cancer Risk

webmd.com — “The fda says a connection between the cholesterol-lowering drug vytorin and cancer risk is unlikely, but cannot be ruled out.View full resource at webmd.com

  • View Related
  • Share

Most Recently Shared on December 23, 2009 at 12:31 am By:

WebMD_News WebMD_News Health News

FDA: Vytorin Unlikely to Up Cancer Risk: The FDA has backed off a 2008 statement describing a possible link between... http://bit.ly/4PbWLG

2 years ago...

Sensationalizing research

theheart.org — “A new editorial addresses the current challenges of clinical research, particularly the need to avoid public, media, and clinical sensationalism regarding new drugs and devices. With big drugs coming to market affecting a large number of patients, clinicians need to properly put the risks and benefits into context and to trust the structures already in place to manage adverse-event signals, say the editorialists.View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on April 19, 2010 at 12:57 pm By:

theheartorg Shelley Wood Cardiology

This drug kills patients! Avoiding sensationalism in clinical trials: A new editorial addresses the current challe... http://bit.ly/aEswRr

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • eyeonfda

    eyeonfda

    Author of the blog Eye on FDA - www.eyeonfda.com

    View Profile

  • theheartorg

    Shelley Wood

    Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4

    View Profile

  • theheartorg

    Shelley Wood

    Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390